Management of Hepatitis B Virus Infection in Liver Transplantation Setting; The Rising Concerns and Growing Hopes, Report From 10th Congress of the Iranian Society for Organ Transplantation, 2011, Shiraz, Iran

AUTHORS

Seyed Moayed Alavian 1 , * , Kamran B. Lankarani 2 , Mario Rizzetto 3 , Alfredo Marzano 4 , Mohsen Moghadami 5 , Saman Nik-Eghbolian 6 , Amin Bahrani 6

1 Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, alavian@thc.ir, IR Iran

2 Health Policy Research Center, Shiraz University of Medical Sciences, IR Iran

3 Department of Gastroenterology, Molinette University of Torino, Italy

4 Division of Gastroenterology and Hepatology, San Giovanni Battista Hospital, Italy

5 HIV/AIDS Research Center, Shiraz University of Medical Sciences, IR Iran

6 Shiraz Organ Transplant Unit, Namazee Hospital, Shiraz University of Medical Sciences, IR Iran

How to Cite: Alavian S M, B. Lankarani K , Rizzetto M , Marzano A , Moghadami M , et al. Management of Hepatitis B Virus Infection in Liver Transplantation Setting; The Rising Concerns and Growing Hopes, Report From 10th Congress of the Iranian Society for Organ Transplantation, 2011, Shiraz, Iran, Hepat Mon. 2012 ; 12(12):8094. doi: 10.5812/hepatmon.8094.

ARTICLE INFORMATION

Hepatitis Monthly: 12 (12); 8094
Published Online: December 30, 2012
Article Type: Meeting Report
Received: August 1, 2012
Accepted: September 8, 2012
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Hepatitis B infection is the main cause of liver related mortality in many countries including Iran. Liver transplantation in cirrhosis due to HBV infection before 1990 was an absolute contraindication. Recurrent infection was a significant event in post liver transplant setting and resulted in increased risk of graft failure and death except successful transplanted individuals. Advances in antiviral prophylaxis have now made graft reinfection majority patients as a rare event. Graft and patient survival have been improved significantly during the past two decades, and consequences of transplantation for hepatitis B virus are now superior to those achieved for most other indications. This has encouraged many centers including the major liver transplantation center of Iran, in Shiraz, to provide liver transplantation to more patients with HBV related end stage liver disease. Management of these patients begins before transplantation along with special care after transplantation. There are some myths and doubts in the management of these patients and one should always balance the cost and efficiency. One of the major concerns is the high economic and social cost of recurrence and all possible efforts should be performed to avoid the ominous consequences of reinfection. Having a clear scientific grasp on the management of HBV cirrhosis before and after liver transplantation, options and protocols, and changing the concept which HBV infected are contraindicated ones for liver transplantation, and future hopes in increasing patients survival after liver transplantation using the new nucleosides analogues and availability of hepatitis B immunoglobulin in the transplantation setting. This scientific report paper outlines the insights communicated at the HBV and liver transplantation symposium during 10th Congress of the Iranian Society for Organ Transplantation, May 2011, Shiraz, Iran.

Keywords

Liver Transplantation Hepatitis B Virus Hepatitis B Hyperimmune Globulin Liver Cirrhosis Iran

© 2012, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: